Market Cap 830.54M
Revenue (ttm) 187.34M
Net Income (ttm) -9.96M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -5.32%
Debt to Equity Ratio 0.43
Volume 485,700
Avg Vol 951,628
Day's Range N/A - N/A
Shares Out 46.01M
Stochastic %K 94%
Beta 1.04
Analysts Strong Sell
Price Target $24.75

Company Profile

Axogen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral...

Industry: Medical Devices
Sector: Healthcare
Phone: 386 462 6800
Fax: 386 462 6801
Address:
13631 Progress Boulevard, Suite 400, Alachua, United States
LuckEtradER
LuckEtradER Oct. 25 at 1:00 AM
$AXGN so bullish here next 60 days
0 · Reply
Titleist123
Titleist123 Oct. 24 at 5:16 PM
$AXGN what does FDA approval bring us to- $25/30?
1 · Reply
LuckEtradER
LuckEtradER Oct. 22 at 9:31 PM
$AXGN cup and handle on the 6 month? Ties in nicely to Dec 5th decision looming 👀
1 · Reply
dustin1101
dustin1101 Oct. 21 at 2:28 PM
$AXGN $18’s on the way again it looks.
0 · Reply
PremarketAnalysis
PremarketAnalysis Oct. 19 at 1:34 AM
$AXGN SignalEngine: MM Infl (Bullish) (1h bias), Algo Vol 45%, Org Vol 55%, Res 17.08, Sup 15.48 Algo Int: Spoofing tape to stall action.. synthetic rotation developing within profit zone. Momentum Feed: https://premarketanalysis.com/#momentum=AXGN
0 · Reply
Biobrocker12
Biobrocker12 Oct. 16 at 9:09 AM
$AXGN free fda approval research https://docs.google.com/document/d/14-EwuIcWXfDa2wHZj_NlXykbXc4_D7m3Gmt36zRvHfA/edit?usp=drivesdk
1 · Reply
LuckEtradER
LuckEtradER Oct. 16 at 12:21 AM
$AXGN 12/5
0 · Reply
BrennadPurdysw
BrennadPurdysw Oct. 12 at 5:47 PM
CVKD Exciting news: Cadrenal Therapeutics Company Webcast @ Lytham Partners Fall 2025 Investor Conference. Watch live here: https://youtu.be/NfPbBjgeIbg?si=2xPvJ2_YJQjHipGa $CVM $TARS $AROC $AXGN $RGR
0 · Reply
BioTechHealthX
BioTechHealthX Oct. 12 at 5:07 PM
$AXGN Revenue jumped 17.4% year-over-year as Axogen nears its FDA BLA decision. Analysts project up to 60% upside before the December 5 ruling. https://biotechhealthx.com/biotech-news/axogen-axgn-surges-toward-26-target-as-nerve-repair-demand-soars-17/
0 · Reply
Tain0os
Tain0os Oct. 10 at 8:38 PM
$SPY $CSPX (Ireland S&P 500) firm long at the EU open tomorrow. Opened Q4 net longs today -> $RGNX $OMER $INVA $AXGN
1 · Reply
Latest News on AXGN
Axogen, Inc. (AXGN) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 1:15 PM EDT - 2 months ago

Axogen, Inc. (AXGN) Q2 2025 Earnings Call Transcript


Axogen, Inc. (AXGN) Q1 2025 Earnings Call Transcript

May 9, 2025, 3:21 PM EDT - 6 months ago

Axogen, Inc. (AXGN) Q1 2025 Earnings Call Transcript


Axogen, Inc. Reports 2025 First Quarter Financial Results

May 8, 2025, 7:05 AM EDT - 6 months ago

Axogen, Inc. Reports 2025 First Quarter Financial Results


Axogen, Inc. (AXGN) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 1:58 PM EST - 8 months ago

Axogen, Inc. (AXGN) Q4 2024 Earnings Call Transcript


Axogen, Inc. To Host Analyst & Investor Day on March 4th

Feb 25, 2025, 7:10 AM EST - 8 months ago

Axogen, Inc. To Host Analyst & Investor Day on March 4th


Axogen: Well Placed To Capitalize Growth At Higher Multiples

Jan 6, 2025, 8:01 PM EST - 10 months ago

Axogen: Well Placed To Capitalize Growth At Higher Multiples


Axogen, Inc (AXGN) Q3 2024 Earnings Call Transcript

Nov 9, 2024, 9:53 AM EST - 1 year ago

Axogen, Inc (AXGN) Q3 2024 Earnings Call Transcript


Apple, Inc. (AXGN) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 2:10 PM EDT - 1 year ago

Apple, Inc. (AXGN) Q2 2024 Earnings Call Transcript


Axogen, Inc. Announces New Leadership Appointments

Aug 8, 2024, 7:05 AM EDT - 1 year ago

Axogen, Inc. Announces New Leadership Appointments


AxoGen, Inc. (AXGN) Q1 2024 Earnings Call Transcript

May 5, 2024, 1:21 AM EDT - 1 year ago

AxoGen, Inc. (AXGN) Q1 2024 Earnings Call Transcript


Axogen, Inc Reports First Quarter 2024 Financial Results

May 2, 2024, 7:00 AM EDT - 1 year ago

Axogen, Inc Reports First Quarter 2024 Financial Results


AxoGen, Inc. (AXGN) Q4 2023 Earnings Call Transcript

Mar 5, 2024, 11:03 AM EST - 1 year ago

AxoGen, Inc. (AXGN) Q4 2023 Earnings Call Transcript


Axogen Announces Promotions on Research and Development Team

Jan 4, 2024, 4:35 PM EST - 1 year ago

Axogen Announces Promotions on Research and Development Team


Axogen, Inc. Appoints Kathy Weiler to its Board of Directors

Dec 26, 2023, 4:15 PM EST - 1 year ago

Axogen, Inc. Appoints Kathy Weiler to its Board of Directors


Axogen Announces Transition of Finance Team Leadership

Dec 6, 2023, 7:00 AM EST - 2 years ago

Axogen Announces Transition of Finance Team Leadership


AxoGen, Inc. (AXGN) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 9:49 AM EST - 2 years ago

AxoGen, Inc. (AXGN) Q3 2023 Earnings Call Transcript


Axogen, Inc. Reports 2023 Third Quarter Financial Results

Nov 7, 2023, 7:00 AM EST - 2 years ago

Axogen, Inc. Reports 2023 Third Quarter Financial Results


Axogen to Participate at Upcoming Investor Conferences

Aug 31, 2023, 7:00 AM EDT - 2 years ago

Axogen to Participate at Upcoming Investor Conferences


AxoGen, Inc. (AXGN) Q2 2023 Earnings Call Transcript

Aug 7, 2023, 9:34 PM EDT - 2 years ago

AxoGen, Inc. (AXGN) Q2 2023 Earnings Call Transcript


Axogen, Inc. Reports 2023 Second Quarter Financial Results

Aug 7, 2023, 4:01 PM EDT - 2 years ago

Axogen, Inc. Reports 2023 Second Quarter Financial Results


LuckEtradER
LuckEtradER Oct. 25 at 1:00 AM
$AXGN so bullish here next 60 days
0 · Reply
Titleist123
Titleist123 Oct. 24 at 5:16 PM
$AXGN what does FDA approval bring us to- $25/30?
1 · Reply
LuckEtradER
LuckEtradER Oct. 22 at 9:31 PM
$AXGN cup and handle on the 6 month? Ties in nicely to Dec 5th decision looming 👀
1 · Reply
dustin1101
dustin1101 Oct. 21 at 2:28 PM
$AXGN $18’s on the way again it looks.
0 · Reply
PremarketAnalysis
PremarketAnalysis Oct. 19 at 1:34 AM
$AXGN SignalEngine: MM Infl (Bullish) (1h bias), Algo Vol 45%, Org Vol 55%, Res 17.08, Sup 15.48 Algo Int: Spoofing tape to stall action.. synthetic rotation developing within profit zone. Momentum Feed: https://premarketanalysis.com/#momentum=AXGN
0 · Reply
Biobrocker12
Biobrocker12 Oct. 16 at 9:09 AM
$AXGN free fda approval research https://docs.google.com/document/d/14-EwuIcWXfDa2wHZj_NlXykbXc4_D7m3Gmt36zRvHfA/edit?usp=drivesdk
1 · Reply
LuckEtradER
LuckEtradER Oct. 16 at 12:21 AM
$AXGN 12/5
0 · Reply
BrennadPurdysw
BrennadPurdysw Oct. 12 at 5:47 PM
CVKD Exciting news: Cadrenal Therapeutics Company Webcast @ Lytham Partners Fall 2025 Investor Conference. Watch live here: https://youtu.be/NfPbBjgeIbg?si=2xPvJ2_YJQjHipGa $CVM $TARS $AROC $AXGN $RGR
0 · Reply
BioTechHealthX
BioTechHealthX Oct. 12 at 5:07 PM
$AXGN Revenue jumped 17.4% year-over-year as Axogen nears its FDA BLA decision. Analysts project up to 60% upside before the December 5 ruling. https://biotechhealthx.com/biotech-news/axogen-axgn-surges-toward-26-target-as-nerve-repair-demand-soars-17/
0 · Reply
Tain0os
Tain0os Oct. 10 at 8:38 PM
$SPY $CSPX (Ireland S&P 500) firm long at the EU open tomorrow. Opened Q4 net longs today -> $RGNX $OMER $INVA $AXGN
1 · Reply
Tain0os
Tain0os Oct. 10 at 8:33 PM
$AXGN started with a small long position in the low intraday
0 · Reply
LuckEtradER
LuckEtradER Oct. 9 at 10:08 PM
$AXGN good op w/ pending approval early December IMO
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 9 at 4:03 PM
Results of list 9/26/25 $AXGN $AXL $AXP Cycle Trading Signal plugged into AI 🔥
0 · Reply
dustin1101
dustin1101 Oct. 7 at 1:40 PM
$AXGN Adding shares back again.
0 · Reply
kgnfdeagle
kgnfdeagle Oct. 3 at 4:30 PM
$AXGN Long from $18.00 -- Zacks Homerun pick.
1 · Reply
Quantumup
Quantumup Oct. 2 at 11:05 AM
Canaccord Genuity yesterday reiterated $AXGN at a Buy rating and a $24 price target. $XBI $IBB Canaccord Genuity today reiterated AxoGen, Inc. (AXGN) at a Buy rating and $24 price target. Canaccord Genuity's note from y'day also answers some questions y'all may have on the Shutdown in regards to the HHS/FDA and what in means to the Healthcare Industry. Canaccord Genuity said in its notes to investors:
0 · Reply
LuckEtradER
LuckEtradER Oct. 1 at 11:36 PM
0 · Reply
dustin1101
dustin1101 Oct. 1 at 2:31 PM
$AXGN Weak handed buyers from yesterday’s H.C. W coverage are discovering this is a thin stock and they’re pounding out with 70K total volume traded.. this will turn back up IMO. Amateur hour.
1 · Reply
JarvisFlow
JarvisFlow Sep. 30 at 10:56 AM
HC Wainwright & Co. updates rating for Axogen ( $AXGN ) to Buy, target set at 25.
0 · Reply
healthcareguru
healthcareguru Sep. 30 at 2:04 AM
Healthcare M&A Takeout / Must-Own Basket: $AXGN $AVTR $ADMA $EVH $SGRY 🔥💪👍💵
1 · Reply
GFstocktwits
GFstocktwits Sep. 29 at 12:46 PM
$AXGN why buy a "second runner", take a look at RNV on the asx when you feel like it
0 · Reply
dustin1101
dustin1101 Sep. 24 at 7:40 PM
$AXGN Just keep buying the dips.. Added back what I sold 17.65 at 17.10 today. Steady freight train momentum as buyers continue to slowly accumulate.
0 · Reply